Controlled Trial of Prenatal Vitamin D3 Supplementation to Prevent Vitamin D Deficiency in Mothers and Their Infants

• Status: Completed
• Trial end date: 2012-04-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this research study is to compare the effects of higher dose vitamin D with commonly recommended dose in pregnant women to see which is better in achieving and/or maintaining sufficient vitamin D blood levels during pregnancy and in newborn infants as well as improving growth in the infant.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Children's Hospital Medical Center, Cincinnati
• Collaborators: Thrasher Research Fund; United Arab Emirates University
• Treatments: Cholecalciferol; Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• Women who are within the ages of 18-45 years

• In good general health

• 12 weeks pregnant (based on last menstrual period)

Exclusion Criteria:

• Mothers with preexisting type I or type II diabetes

• Mothers with preexisting hypertension

• Mothers with preexisting parathyroid disease or uncontrolled thyroid disease

• Mothers with multiple fetuses (e.g., twins, triplets, etc.)